Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a new revision entry v3.4.3 and removed the previous entry v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-11T14:44:54.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history. The deletions include a funding notice and the prior revision (v3.4.1).
    Difference
    0.6%
    Check dated 2026-02-11T01:54:38.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide government funding notice was added and the record revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-03T23:25:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI improvements include a glossary toggle, color-coded change indicators for additions and deletions, and an updated revision label (v3.4.0).
    Difference
    0.8%
    Check dated 2026-01-27T19:58:51.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page history shows the addition of Revision: v3.3.4 and the removal of Revision: v3.3.3, indicating a minor version update that does not affect study information or user-facing content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T13:58:44.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a new revision entry, v3.3.3, to the Record History. The HHS Vulnerability Disclosure and the previous revision entry (v3.3.2) were removed from the page footer/history.
    Difference
    0.2%
    Check dated 2025-12-22T23:43:52.000Z thumbnail image

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.